6-[18F]Fluorodopa

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug Name6-[18F]Fluorodopa
Drug Alias Name氟[18F]多巴FDOPA18F-Fluorodopa6-[18F]氟-L-多巴6-fluoro-18[F]-L-DOPA +[13] 
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancers
TargetsNot applicable
Therapy Area/IndicationsDiagnostic agentsHyperinsulinismParkinsonian Disorders +[5] 
Global Approved IndicationsDiagnostic agentsParkinsonian Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritorySwitzerland
Original Approved Date2016/11/01
Country/TerritoryUnited StatesSwitzerlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Huayi Nuclear Medicine Co LtdFeinstein Institute For Medical ResearchWashington University School Of Medicine +[5] 
Inactive CompaniesUniversity Of California, Los Angeles
Active IndicationsDiagnostic agentsHyperinsulinismParkinsonian Disorders
Inactive IndicationsGlioblastomaGlioma

Other Information

ATC CodeV09IX
Related LinksN/A